
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.47 | 1.47 | 0.00 |
Shares | 96.61 | 96.61 | 0.00 |
Other | 1.92 | 1.92 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.21 | 19.62 |
Price to Book | 6.22 | 4.36 |
Price to Sales | 6.66 | 2.36 |
Price to Cash Flow | 15.88 | 15.71 |
Dividend Yield | 1.14 | 1.14 |
5 Years Earnings Growth | 7.80 | 11.11 |
Number of long holdings: 79
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 18.02 | 230.19 | -1.59% | |
Alnylam | US02043Q1076 | 8.56 | 451.95 | -0.96% | |
Gilead | US3755581036 | 7.48 | 113.59 | +0.80% | |
argenx ADR | US04016X1019 | 5.27 | 787.94 | -1.51% | |
Ascendis Pharma AS | US04351P1012 | 5.06 | 211.20 | +3.50% | |
Amgen | US0311621009 | 4.39 | 294.09 | -1.28% | |
Insmed | US4576693075 | 2.58 | 158.28 | +0.71% | |
Nuvalent Inc Class A | - | 2.29 | - | - | |
Viridian Therapeutics | US92790C1045 | 2.20 | 20.83 | -3.79% | |
Soleno Therapeutics | US8342033094 | 2.13 | 58.4500 | -1.28% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 681.82B | 10.78 | 19.52 | 14.59 | ||
Fidelity Contrafund | 160.4B | 15.64 | 27.85 | 16.71 | ||
Fidelity Total Market Index Instl b | 113.87B | 10.54 | 18.84 | 13.93 | ||
Fidelity Blue Chip Growth | 67.4B | 10.09 | 28.45 | 18.90 | ||
Fidelity Growth Company | 64.44B | 10.78 | 27.12 | 19.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review